BLS stimulation does not protect mice with B16 melanoma at 10 days of tumor inoculation.

<p>C57Bl/6J mice were inoculated with 2.5x10⁵ B16-OVA cells sc in the right flank; 10 days later, mice were injected sc in the base of the tail with 100 μg of BLS or BLS-OVA or left untreated (control). Tumor growth was monitored; curves show survival rate; n = 6.